HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,658,160 | +3.6% | 52,000 | -1.5% | 0.02% | +6.7% |
| Q2 2023 | $4,495,392 | +19.9% | 52,800 | +16.6% | 0.02% | +15.4% |
| Q1 2023 | $3,748,575 | +1078.8% | 45,300 | +906.7% | 0.01% | +1200.0% |
| Q3 2021 | $318,000 | -69.9% | 4,500 | -52.6% | 0.00% | -66.7% |
| Q1 2021 | $1,055,000 | -6.5% | 9,500 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $1,128,000 | +36.1% | 9,500 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $829,000 | -57.1% | 9,500 | -56.0% | 0.00% | -25.0% |
| Q2 2020 | $1,934,000 | -10.1% | 21,600 | 0.0% | 0.00% | -20.0% |
| Q1 2020 | $2,152,000 | +126.3% | 21,600 | +1.9% | 0.01% | +25.0% |
| Q3 2017 | $951,000 | +225.7% | 21,200 | +194.4% | 0.00% | +300.0% |
| Q1 2017 | $292,000 | -53.8% | 7,200 | -67.0% | 0.00% | -66.7% |
| Q2 2016 | $632,000 | – | 21,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |